| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.8M | -2.8% |
| Cost of Revenue | $1.6M | -28.7% |
| Gross Profit | $4.2M | +13.2% |
| R&D Expense | $2.4M | +38.4% |
| SG&A Expense | $9.3M | -24.1% |
| Operating Income | -$13.6M | +31.6% |
| Pre-tax Income | -$8.2M | +59.3% |
| Net Income | -$8.2M | +59.3% |
| EPS (Basic) | -$6.35 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.3M | +41.1% |
| Accounts Receivable | $2.2M | +5.5% |
| Inventory | $1.6M | -11.3% |
| Current Assets | $20.4M | +39.0% |
| Total Assets | $33.8M | +4.2% |
| Current Liabilities | $10.8M | +52.4% |
| Total Liabilities | $21.3M | +35.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.6M | +40.4% |
| Financing Cash Flow | $11.5M | +810.4% |
| +34.4% |
| EPS (Diluted) | -$6.35 | +34.4% |
| Stockholders' Equity |
| $12.1M |
| -27.7% |